₹3,000 but now, with modification, the cost has been brought down to ₹300. This will help in saving severe anaemic cases and life saving intervention," said Dr Kapil Yadav, a researcher at AIIMS Delhi.
Experts are hoping that the molecules can also be developed in India in the future, which will help to further cut costs. "We are trying to encourage generic version of the molecule in India; we want the pharma industries to take it up.
In western countries, the molecule is used for kidney or cancer cases since there aren't much anaemia reports among women. But here, it can be a game changer and not just in India -- the plan should involve exporting it to South Asian countries as well," Dr Yadav said.
Read more on livemint.com